Is TSON a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

138 people get TSON articles and Market Currents by email alert.

Get email alerts on TSON »

HEADLINES:

TranS1 Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 9
TranS1 Inc. Reports Operating Results for the First Quarter of 2013, Issues Second Quarter 2013 Guidance

GlobeNewswire (May 9, 2013)
TranS1 Inc. Schedules First Quarter 2013 Results Conference Call for Thursday, May 9, 2013

GlobeNewswire (Apr 26, 2013)
TranS1 Inc. Announces Participation in Canaccord Genuity Musculoskeletal Conference

GlobeNewswire (Mar 14, 2013)
TranS1 Management Discusses Q4 2012 Results - Earnings Call Transcript
Mon, Mar 4 • 1 Comment
TranS1 Inc. Announces Agreement to Acquire Baxano, Inc. and $17.2M Financing Commitment

GlobeNewswire (Mar 4, 2013)
TranS1 Inc. Reports Operating Results for the Fourth Quarter of 2012, Issues First Quarter 2013 Guidance

GlobeNewswire (Mar 4, 2013)
TranS1 Inc. Announces Participation in Two Healthcare Conferences

GlobeNewswire (Feb 21, 2013)
TranS1 Inc. Schedules Fourth Quarter 2012 Results Conference Call for Monday, March 4, 2013

GlobeNewswire (Feb 20, 2013)
TranS1 Appoints Mark Stautberg to Board of Directors

GlobeNewswire (Feb 19, 2013)
TranS1 Inc. Announces Coverage Milestone

GlobeNewswire (Feb 11, 2013)
TranS1 Inc. Announces Preliminary Unaudited Fourth Quarter 2012 Revenue

GlobeNewswire (Jan 14, 2013)
TranS1 Inc. Announces Tentative Settlement With Office of Inspector General

GlobeNewswire (Dec 27, 2012)
TranS1 Inc. Announces Participation at the 2012 Piper Jaffray Healthcare Conference

GlobeNewswire (Nov 14, 2012)
TranS1 Inc. Reports Operating Results for the Third Quarter of 2012, Issues Fourth Quarter 2012 Guidance

GlobeNewswire (Nov 8, 2012)
TranS1 Inc. Announces Category I Physician Payment Rates for Single Level AxiaLIF Fusion

GlobeNewswire (Nov 2, 2012)
TranS1 Inc. Announces Participation at the 2012 Lazard Capital Markets Healthcare Conference

GlobeNewswire (Nov 1, 2012)
TranS1 Inc. Schedules Third Quarter 2012 Results Conference Call for Thursday, November 8, 2012

GlobeNewswire (Oct 25, 2012)
China Biotech In Review: SFDA Drug Approvals Drop In 2011
ChinaBio Today • Sun, Oct 14, 2012
TranS1 Inc. Announces Distribution Agreement in China

GlobeNewswire (Oct 10, 2012)

To learn more about Seeking Alpha Pro, click here.

TranS1 IPO Surges 60% On First Day
Tom Taulli • Wed, Oct 17, 2007 • 2 Comments
Medical Device Company Trans1 Files For IPO
Sara Calabro • Fri, Jul 27, 2007

China Biotech In Review: SFDA Drug Approvals Drop In 2011
ChinaBio Today • Sun, Oct 14, 2012
7 Rallying Stocks Under $5 Being Sold Off By Hedge Funds
Kapitall • Thu, May 3, 2012
6 Insider Stock Picks Rated Buy By Canaccord Genuity
Kapitall • Fri, Feb 10, 2012 • 2 Comments
8 Oversold Healthcare Stocks Being Bought Up By Insiders
Kapitall • Tue, Sep 20, 2011 • 1 Comment
16 Stocks Under $5 Being Bought Up By Insiders And The Smart Money
Kapitall • Fri, Sep 16, 2011
Thomas Weisel's Small Cap Technology and Healthcare Picks for Q2
GuruFundPicks • Sun, Aug 7, 2011
19 Micro Cap Stocks Being Dumped by Mutual Funds
Kapitall • Tue, May 3, 2011 • 6 Comments
In Search of Healthcare Diamonds in the Rough
Mike Havrilla • Tue, Jan 13, 2009 • 2 Comments
This Week's IPOs: DuPont Fabros Technology, Maxcom Telecommunications, Noah Education Holdings, Rodman & Renshaw Capital Group, SoundBite Communications, Trans1 Inc.
SA Editor Abbi Adest • Sun, Oct 14, 2007

TranS1 Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 9
TranS1 Management Discusses Q4 2012 Results - Earnings Call Transcript
Mon, Mar 4 • 1 Comment
TranS1, Inc. Q1 2010 Earnings Call Transcript
Tue, May 4, 2010
TranS1, Inc. Q1 2009 Earnings Call Transcript
Mon, Apr 27, 2009
TranS1 Inc. Q4 2008 Earnings Call Transcript
Mon, Feb 23, 2009
TranS1 Inc. Q2 2008 Earnings Call Transcript
Mon, Aug 4, 2008
TranS1 Inc. Q1 2008 Earnings Call Transcript
Tue, May 13, 2008

TranS1 Inc. Reports Operating Results for the First Quarter of 2013, Issues Second Quarter 2013 Guidance

GlobeNewswire (May 9, 2013)
TranS1 Inc. Schedules First Quarter 2013 Results Conference Call for Thursday, May 9, 2013

GlobeNewswire (Apr 26, 2013)
TranS1 Inc. Announces Participation in Canaccord Genuity Musculoskeletal Conference

GlobeNewswire (Mar 14, 2013)
TranS1 Inc. Announces Agreement to Acquire Baxano, Inc. and $17.2M Financing Commitment

GlobeNewswire (Mar 4, 2013)
TranS1 Inc. Reports Operating Results for the Fourth Quarter of 2012, Issues First Quarter 2013 Guidance

GlobeNewswire (Mar 4, 2013)
TranS1 Inc. Announces Participation in Two Healthcare Conferences

GlobeNewswire (Feb 21, 2013)
TranS1 Inc. Schedules Fourth Quarter 2012 Results Conference Call for Monday, March 4, 2013

GlobeNewswire (Feb 20, 2013)
TranS1 Appoints Mark Stautberg to Board of Directors

GlobeNewswire (Feb 19, 2013)
TranS1 Inc. Announces Coverage Milestone

GlobeNewswire (Feb 11, 2013)
TranS1 Inc. Announces Preliminary Unaudited Fourth Quarter 2012 Revenue

GlobeNewswire (Jan 14, 2013)
TranS1 Inc. Announces Tentative Settlement With Office of Inspector General

GlobeNewswire (Dec 27, 2012)
TranS1 Inc. Announces Participation at the 2012 Piper Jaffray Healthcare Conference

GlobeNewswire (Nov 14, 2012)
TranS1 Inc. Reports Operating Results for the Third Quarter of 2012, Issues Fourth Quarter 2012 Guidance

GlobeNewswire (Nov 8, 2012)
TranS1 Inc. Announces Category I Physician Payment Rates for Single Level AxiaLIF Fusion

GlobeNewswire (Nov 2, 2012)
TranS1 Inc. Announces Participation at the 2012 Lazard Capital Markets Healthcare Conference

GlobeNewswire (Nov 1, 2012)
TranS1 Inc. Schedules Third Quarter 2012 Results Conference Call for Thursday, November 8, 2012

GlobeNewswire (Oct 25, 2012)
TranS1 Inc. Announces Distribution Agreement in China

GlobeNewswire (Oct 10, 2012)
TranS1 Inc. Announces Appointment of Stephanie M. Fitts, Ph.D. as Vice President of Regulatory, Quality and Compliance

GlobeNewswire (Sep 17, 2012)
TranS1 Inc. Announces Participation at the 2012 Stifel Nicolaus Healthcare Conference

GlobeNewswire (Aug 28, 2012)
TranS1 Inc. Reports Operating Results for the Second Quarter of 2012, Issues Third Quarter 2012 Guidance

GlobeNewswire (Aug 9, 2012)

TSON vs. ETF Alternatives

Company Description

Currently, there's no company description for TSON.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 10, 6:22 AM TranS1 (TSON): Q1 EPS of -$0.21 misses by $0.01. Revenue of $3.1M misses by $0.16M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Monday, March 4, 7:03 AM TranS1 (TSON): Q4 EPS of -$0.20. Revenue of $4.0M (+2.5% Y/Y). (PR) Comment! [Earnings, Breaking News, Healthcare]
Friday, December 28, 2012, 1:12 PM Trans1 (TSON -2.4%) dips after announcing a tentative $6M agreement with the DoJ to settle an investigation launched last year by the Department of Health and Human Services' Office of Inspector General. The investigation involved federal healthcare fraud and violating false claims statutes, for which the government issued a subpoena in October 2011 seeking company documents from January 2008 through October, 2011. Comment! [Healthcare]
Thursday, December 13, 2012, 5:37 PM After-hours top gainers, as of 5:15 p.m.: ADBE +5%. SCVL +2%. GWAY +2%. ONNN +2%. AVGO +2%.
After-hours top losers: ZQK -14%. CYTX -13%. VGZ -9%. PAY -6%. TSON -6%. Comment! [On the Move]
Friday, October 12, 2012, 12:45 PM Midday top 10 gainers: NINE +62%. CRMB +16%. NPSP +15%. AEGR +13%. GLUU +12%. LXRX +11%. TSON +11%. BIOF +10%. EMAN +10%. BSDM +9%.
Top 10 Losers: AEZS -24%. OCZ -17%. TZOO -14%. PURE -11%. INVE -11%. AMD -10%. LQDT -10%. CCCL -9%. INFY -9%. Comment! [On the Move]
Friday, March 9, 2012, 12:40 PM TranS1 (TSON -5.3%) dips after posting disappointing Q4 results. Revenue fell 32% Y/Y despite a sharp improvement in margins, as the company continues to post declining revenue and quarterly losses. Additionally, the medical device maker forecast Q1 revenue to be lower, now expecting to earn between $3.5M - $3.9M, below the Street consensus forecast of $4M. Comment! [Earnings, Healthcare, On the Move]
Monday, March 5, 2012, 7:35 AM TranS1 (TSON) announces that the AMA approved one of its application for a spinal implant that aims to help treat degenerative back conditions. The company says it will provide more details on the product during its Q4 conference call - slated for March 8th. Shares +26.8% premarket. Comment! [Healthcare, On the Move]
Monday, February 27, 2012, 2:23 PM TranS1 (TSON +13.3%) jumps after Canaccord raises the shares to Buy, saying management's recent actions to re-initiate enrollment in a prospective trial as well as undertaking new physician education programs reflects the company's confidence in its current strategy to drive reimbursement at both the federal and private payor levels. Comment! [Healthcare, On the Move]
Monday, September 26, 2011, 1:51 PM TranS1 (TSON +6.5%) is trading higher today after closing out its previously announced secondary offering of 6.2M shares and pricing it at $3.25. Comment! [On the Move]

Dr. Kris
Biotechs on fire: Spinal implant maker TSON more than doubling in past two weeks to $4.25 on heavy volume. No news--possible takeover?
1/19/11
Reply (1)

• !Report Abuse
View all 1 replies
Thomas Garrity: "TSON"- Current procedural terminology decision by AMA- will be a jolt to pps (not Chevy Volt)!!
3/3/12
• !Report Abuse
Add a reply...

140 characters

fxretracer
Current stock positions: $IAU @ 13.66 $ZN @ 5.37 $ FCPG @ 1.76 $TSON @ 3.30. Long term hold(three to six months).
1/18/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

DFraser
looking for shorts in V, MA...Also following SEED, CAGC.PK, CREE, TSON
9/8/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

AlphaLoboTrading
TSON-company focused on designing developing products that implement minimally invasive surgical approach to treat degenerative discs
9/28/09
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Dr. Kris
Biotechs on fire: Spinal implant maker TSON more than doubling in past two weeks to $4.25 on heavy volume. No news--possible takeover?
1/19/11
Reply (1)

• !Report Abuse
View all 1 replies
Thomas Garrity: "TSON"- Current procedural terminology decision by AMA- will be a jolt to pps (not Chevy Volt)!!
3/3/12
• !Report Abuse
Add a reply...

140 characters

TSON TranS1 Inc.

TSON

TranS1 Inc.